The number of people with susceptibility test result for rifampicin in Maldives

Maldives: The number of people with susceptibility test result for rifampicin was 95.83 in 2021. ▲ Rising

Latest (2021)
95.83
Change on year
up 53.8%
World rank
50th
of 146 countries
All-time high
96.43
in 2019
All-time low
59.05
in 2018
Years of data
5
2017–2021

The number of people with susceptibility test result for rifampicin in Maldives, 2017–2021

0204060801002017201920212017: 59.82018: 592019: 96.42020: 62.32021: 95.8

Source: World Health Organization, Global Health Observatory.

Analysis

Maldives recorded 95.83 for the number of people with susceptibility test result for rifampicin in 2021.

That represents a change of up 53.8% on the previous year and up 60.3% over five years.

Maldives ranks 50th of 146 countries on this measure, in the middle of the range.

The number of people with susceptibility test result for rifampicin in Maldives, year by year

Annual values for The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage. in Maldives, 2017 to 2021.
Year Value Change
2017 59.79
2018 59.05 -1.2%
2019 96.43 +63.3%
2020 62.32 -35.4%
2021 95.83 +53.8%

Maldives compared with similar countries

  • Maldives's 95.83 is above the median for upper middle income countries, which is 92.7, 1.0× the median. (45 countries reporting)
  • Maldives's 95.83 is above the median for South Asia, which is 81.26, 1.2× the median. (5 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2010s 71.76 59.05 96.43 3
2020s 79.08 62.32 95.83 2

Countries ranked near Maldives

  1. 47 Azerbaijan 96.11 compare
  2. 48 Estonia 96.1 compare
  3. 49 Ghana 96.1 compare
  4. 51 Guatemala 95.02 compare
  5. 52 Hong Kong, China 94.83 compare
  6. 53 United States of America 94.32 compare

See the full ranking of 148 places →

More health data for Maldives

All data for Maldives →

Frequently asked questions

What is the number of people with susceptibility test result for rifampicin in Maldives?
The number of people with susceptibility test result for rifampicin in Maldives was 95.83 in 2021, according to World Health Organization, Global Health Observatory.
What is the highest the number of people with susceptibility test result for rifampicin recorded in Maldives?
The highest recorded value was 96.43 in 2019.
What is the lowest the number of people with susceptibility test result for rifampicin recorded in Maldives?
The lowest recorded value was 59.05 in 2018.
How does Maldives rank for the number of people with susceptibility test result for rifampicin?
Maldives ranks 50th out of 146 countries with data for 2021.
Where does this Maldives data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

The number of people with susceptibility test result for rifampicin in Maldives. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 15 September 2026, from https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among-2/maldives/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among-2/maldives/">The number of people with susceptibility test result for rifampicin in Maldives</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
148 places, 740 data points, 2017–2021
Last refreshed